Back to Journals » OncoTargets and Therapy » Volume 16

Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date

Total article views   HTML views PDF downloads Totals
8,529 Dovepress* 4,233+ 116 4,349
PubMed Central* 4,296 476 4,772
Totals 8,529 592 9,121
*Since 23 March 2023
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 4 8

View citations on PubMed Central and Google Scholar